Commentary Open Access
Seizing the Opportunity: HealthySteps and the Case for Population-Level Infant and Early Childhood Mental Health in Pediatric Care
Rahil D. Briggs1,2,*, Stacey Carpenter2, Laura M. Krug2, Sarah MacLaughlin2, Shay-Lee Perez3
- 1Department of Pediatrics and Psychiatry, Albert Einstein College of Medicine, Bronx, NY, USA
- 2HealthySteps, ZERO to THREE, Washington, DC, USA
- 3Division of Integrated Behavioral Health, Department of Psychiatry, UCSF Center for Advancing Dyadic Care Pediatrics, San Francisco, CA USA
Corresponding Author
Rahil D. Briggs, rbriggs@zerotothree.org
Received Date: June 05, 2026
Accepted Date: July 17, 2026
Briggs RD, Carpenter S, Krug LM, MacLaughlin S, Perez SL. Seizing the Opportunity: HealthySteps and the Case for Population-Level Infant and Early Childhood Mental Health in Pediatric Care. J Ment Health Disord. 2026;6(1):121–126.
Copyright: © 2026 Briggs RD, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
To Quell Childhood Obesity: The Pacific Ending Childhood Obesity Network’s Response
The need to accelerate collective and concerted action to combat Non-Communicable Diseases (NCDs) and childhood obesity is particularly relevant in the Pacific context.
Varying Presentations of EBV-associated Clinical Entities with Emphasis on EBV-Associated T- and NK-cell Lymphoproliferative Disorders of Childhood
The Epstein-Barr Virus (EBV) is an endemic human herpesvirus, with 90% of people demonstrating serological evidence of prior exposure to EBV. In most cases, primary infections of EBV generate mild or asymptomatic clinical courses, but may present as infectious mononucleosis if contracted during young adulthood. In a small percentage of cases, Epstein- Barr virus infection may manifest as a noncanonical reaction, yielding a wide variety of clinical manifestations.
Off Label Use as an Indicator of Therapeutic Need in Pediatrics
Unapproved use of an approved drug is called “off-label” use. In line with European Medicine Agency’s pharmacovigilance directive, off-label use “relates to situations where a medicinal product is intentionally used for a medical purpose not in accordance with the authorised product information (SmPC).
Mental Health and Collective Trauma among Yazidi Genocide Survivors
The Yazidi population has faced systematic persecution, culminating in the 2014 genocide by the so-called Islamic State (IS). This commentary focuses on the impact of collective trauma on Yazidi mental health, focusing on transgenerational trauma, gender-specific experiences, and culturally adapted therapeutic interventions. The discussion highlights the importance of interdisciplinary approaches that consider cultural and socio-political contexts in the treatment of Yazidi survivors. Addressing these complex mental health challenges requires a holistic framework that integrates psychological, social, and legal support mechanisms.
Non-invasive Treatments for Early Childhood Caries (ECC): A New Era in Pediatric Dentistry
Early childhood caries (ECC) is a pervasive and debilitating disease affecting millions of children worldwide. The traditional restorative approach, although effective, often requires invasive procedures, which can be traumatic for young children [1]. Furthermore, ECC can have far-reaching consequences, including pain, infection, and malocclusion, which can impact a child's quality of life and overall well-being.